...
首页> 外文期刊>Bioorganic and medicinal chemistry >Design, synthesis, biological evaluation and cellular imaging of imidazo[4,5- b ]pyridine derivatives as potent and selective TAM inhibitors
【24h】

Design, synthesis, biological evaluation and cellular imaging of imidazo[4,5- b ]pyridine derivatives as potent and selective TAM inhibitors

机译:咪唑[4,5- B]吡啶衍生物作为有效和选择性TAM抑制剂的设计,合成,生物学评价和细胞成像

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The TAM kinase family arises as a new effective and attractive therapeutic target for cancer therapy, autoimmune and viral diseases. A series of 2,6-disubstituted imidazo[4,5-b]pyridines were designed, synthesized and identified as highly potent TAM inhibitors. Despite remarkable structural similarities within the TAM family, compounds28and25demonstrated high activity and selectivityin vitroagainst AXL and MER, with IC50value of 0.77?nM and 9?nM respectively and a 120- to 900-fold selectivity. We also observed an unexpected nuclear localization for compound10Bb, thanks to nanoSIMS technology, which could be correlated to the absence of cytotoxicity on three different cancer cell lines being sensitive to TAM inhibition.
机译:TAM激酶家族是癌症治疗,自身免疫和病毒疾病的一种新的有效和有吸引力的治疗靶标。 设计了一系列2,6-二取代的咪唑[4,5-B]吡啶,合成并鉴定为高效的TAM抑制剂。 尽管TAM系列内的结构相似性显着,但化合物28和25颗致密的高活性和选择性vitroagainst AXL和MER,IC50Value分别为0.77Ω·Nm和9?Nm,选择性120-至900倍。 由于纳米斯米斯技术,我们还观察到化合物10BB的意外的核定位,这可能与三种不同癌细胞系上没有细胞毒性的缺乏相关性对TAM抑制来相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号